全文获取类型
收费全文 | 5244篇 |
免费 | 360篇 |
国内免费 | 5篇 |
专业分类
5609篇 |
出版年
2023年 | 26篇 |
2022年 | 56篇 |
2021年 | 109篇 |
2020年 | 72篇 |
2019年 | 88篇 |
2018年 | 129篇 |
2017年 | 82篇 |
2016年 | 154篇 |
2015年 | 236篇 |
2014年 | 255篇 |
2013年 | 373篇 |
2012年 | 422篇 |
2011年 | 379篇 |
2010年 | 236篇 |
2009年 | 225篇 |
2008年 | 331篇 |
2007年 | 302篇 |
2006年 | 299篇 |
2005年 | 271篇 |
2004年 | 224篇 |
2003年 | 231篇 |
2002年 | 194篇 |
2001年 | 91篇 |
2000年 | 71篇 |
1999年 | 59篇 |
1998年 | 42篇 |
1997年 | 34篇 |
1996年 | 41篇 |
1995年 | 36篇 |
1994年 | 25篇 |
1993年 | 20篇 |
1992年 | 42篇 |
1991年 | 36篇 |
1990年 | 42篇 |
1989年 | 27篇 |
1988年 | 30篇 |
1987年 | 29篇 |
1986年 | 23篇 |
1985年 | 14篇 |
1984年 | 18篇 |
1983年 | 22篇 |
1982年 | 19篇 |
1981年 | 16篇 |
1980年 | 14篇 |
1979年 | 23篇 |
1978年 | 14篇 |
1976年 | 11篇 |
1974年 | 15篇 |
1973年 | 13篇 |
1972年 | 11篇 |
排序方式: 共有5609条查询结果,搜索用时 15 毫秒
31.
Dall'Olio Fabio; Mariani Erminia; Tarozzi Andrea; Meneghetti Alessandra; Chiricolo Mariella; Lau Joseph T. Y.; Facchini Andrea 《Glycobiology》1997,7(4):507-513
The extent of processing of N-linked oligosaccharides and thesialylation of the target cell membranes has been positivelycorrelated with resistance to lysis mediated by NK cells, buta conclusive evidence has never been reached. Colon cancer tissuesexpress an increased activity of ß-ga-lactoside 相似文献
32.
Exemestane experience in breast cancer treatment 总被引:2,自引:0,他引:2
P. E. Lnning R. Paridaens B. Thürlimann G. Piscitelli E. di Salle 《The Journal of steroid biochemistry and molecular biology》1997,61(3-6):151-155
Exemestane is a very potent, orally active, selective and long-lasting steroidal irreversible inhibitor of aromatase. It is 150 times more potent than aminoglutethimide (AG) in inhibiting human placental aromatase (Ki of 4.3 and 671 nM, respectively). The compound is presently under phase III evaluation in Europe and the U.S.A. for the treatment of postmenopausal advanced breast cancer (ABC). Clinical pharmacology studies have been carried out with single doses ranging from 0.5 to 800 mg and repeated doses of up to 600 mg a day, in 132 postmenopausal healthy volunteers and in 185 post-menopausal women with ABC. Results obtained using a very specific and sensitive analytical method (high performance liquid chromatography—radioimmunoassay; HPLC—RIA) indicated that exemestane is extremely effective in inhibiting plasma estrogens levels. Estrogen inhibition is clearly evident at 5 mg a day and maximal suppression for E2, E1 and E1S (>85%, >90% and>90%, respectively) is obtained at 10–25 mg a day. Data from non-controlled phase II studies involving more than 400 patients indicated a clear anti-tumour activity in postmenopausal ABC patients failing multiple hormonal treatments. In 62 patients progressing on AG (≥500 mg a day) exemestane treatment resulted in an objective response rate of approximately 24%; disease stabilization ≥24 weeks was observed in an additional 24% of cases. With regard to safety, although daily doses up to 600 mg were administered, the maximal tolerated dose was not achieved; reported symptoms were mainly related to the pharmacological action of the compound and were usually mild to moderate in severity, resulting in the discontinuation of therapy in less than 3% of cases. In conclusion, the available results suggest that exemestane treatment is associated with minimal toxicity, and may be of significant benefit for ABC women who have exhausted conventional therapy. 相似文献
33.
M. P. Francescato T. Talon P. E. di Prampero 《European journal of applied physiology and occupational physiology》1995,71(4):355-361
Energy costs and energy sources in karate (wado style) were studied in eight male practitioners (age 23.8 years, mass. 72.3 kg, maximal oxygen consumption (VO2max) 36.8 ml · min–1 · kg–1) performing six katas (formal, organized movement sequences) of increasing duration (from approximately. 10 s to approximately 80 s). Oxygen consumption (VO2) was determined during pre-exercise rest, the exercise period and the first 270 s of recovery in five consecutive expired gas collections. A blood sample for lactate (la–) analysis was taken 5 min after the end of exercise. The overall amount of O2 consumed during the exercise and in the following recovery increased linearly with the duration of exercise (t) from approximately 1.51 (for t equal to 10.5 s (SD 1.6)) to approximately 5.81, for t equal to 81.5 s (SD 1.0). The energy release from la– production (VO21a
–) calculated assuming that an increase of 1 mmol · l–1 la– corresponded to a VO2 of 3 mlO2 · kg–1 was negligible for t equal to or less than 20 s and increased to 17.3 ml · kg–1 (la– = 5.8 mmol · l–1 above resting values) for t equal approximately to 80 s. The overall energy requirement (VO2eq) as given by the sum of VO2 and VO2la
– was described by VO2eq = 0.87 + 0.071 · t (n = 64; r
2 = 0.91), where VO2eq is in litres and t in seconds. This equation shows that the metabolic power (VO2eq · t
–1) for this karate style is very high: from approximately 9.51 · min–1 for t equal to 10 s to approximately 4.91 · min–1 for t equal to 80 s, i.e. from 3.5 to 1.8 times the subjects' VO2max. The fraction of VO2eq derived from the amount of O2 consumed during the exercise increased from 11% for t equal to 10 s to 41 % for t equal to 80 s whereas VO21a
– was negligible far t equal to or less than 20 s and increased to 13 % o for t equal to 80 s. The remaining fraction (from 90% for t equal to 10 s to 46% for t equal to 80 s), corresponding to the amount of O2 consumed in the recovery after exercise, is derived from anaerobic alactic sources, i.e. from net splitting of high energy phosphates during the exercise. 相似文献
34.
Alessandra Cesano Sophie Visonneau Livia Cioé Steven C. Clark Daniela Santoli 《Cancer immunology, immunotherapy : CII》1995,40(3):139-151
The TALL-104 cell line, originally derived from a patient with T cell leukemia, can be maintained indefinitely in culture in the presence of interleukin-2 (IL-2) and is endowed with a highly potent major-histocompatibilitycomplex (MHC)-non-restricted tumoricidal activity both in vitro and in animal models. The present study analyzes in detail the short- and long-term effects of irradiation and cyclosporin A (CsA) treatment on the growth and tumoricidal function of this T cell clone as compared to polyclonal lymphokine-activated killer (LAK) cell preparations from healthy donors. DNA and RNA syntheses by both TALL-104 and LAK cells were irreversibly arrested a few hours after irradiation with 40 Gy. However, 4-h51Cr-release assays, performed on different days (day 1 to day 7) after irradiation, showed that the cytotoxic efficiency of TALL-104 cells against hematopoietic and solid tumor targets was only modestly reduced, whereas that of LAK cells was severely inhibited. Moreover, the cytotoxic responses to recombinant human IL-2 and IL-12, measured 18 h after irradiation and cytokine addition, were normal in the case of TALL-104 cells but were abolished in the case of LAK cells. Co-culture of IL-2-or IL-12-preactivated TALL-104 cells with a tumor target for 5 days in the absence of cytokines resulted in a lower efficiency of lysis, as compared to the non-irradiated effectors, especially if the initial stimulus was IL-12. These findings suggest the requirement of multiple cytokine stimulation for optimal expression of tumoricidal activity by lethally irradiated TALL-104 cells. CsA, while abrogating TALL-104 cell proliferation at the low dose of 0.5 g/ml, inhibited their cytotoxic function marginally only at high doses (100 g/ml). By contrast, CsA reduced dose-dependently the cytotoxicity of LAK cells starting at very low doses (0.5 g/ml). CsA did not impair the ability of TALL-104 and LAK cells to produce interferon (IFN), tumor necrosis factor (TNF) , and granulocyte/macrophage-colony-stimulatory factor (GM-CSF) in response to IL-2, IL-12, or tumor targets. Irradiation reduced drastically IFN production by LAK, but not TALL-104 cells; release of TNF and GM-CSF by either type of effector was inhibited by 10%–50%, depending on the stimulus. The high resistance of the TALL-104 cells' tumoricidal function to irradiation and immunosuppressive drugs renders this immortal T cell clone a potentially safe and effective reagent for new adoptive-transfer approaches to cancer in MHC-incompatible recipients. 相似文献
35.
Sex differences in eicosanoid production in platelets and vessel walls have been studied in control and n-6 fatty acid supplemented rats. In platelet rich plasma (PRP) of control female rats, arachidonic acid (AA) levels in phospholipids (PL), thromboxane B2 (TxB2) formation following collagen stimulation and aggregatory responses to collagen were higher than in PRP of male rats. 6 keto PGF1α release from PRP-perfused isolated aortas were the same for both sexes, but the antiaggregatory activity of the wall was higher in males than in females, in association with a greater sensitivity of male platelets to prostacyclin.The administration of n-6 fatty acid supplements increased AA level in PL, TxB2 production and aggregation only in male platelets. Production of 6 keto PGF1α and the antiaggregatory activity of aortic walls were reduced after dietary treatment in males, but biochemical and functional parameters were not correlated in females.The results indicate complex sex-related differences in fatty acid metabolism and eicosanoid production, and in responses to n-6 dietary fatty acids in platelets and the vascular system in the rat. 相似文献
36.
A total of 51 restriction sites were recognized within the BK virus genome by the combination of 10 different restriction endonucleases. These sites were mapped and oriented relative to one another as well as to the five fragments generated by the digestion of BK virus DNA with HindIII and EcoRI. The result was a comprehensive physical map suitable for in-depth characterization of the functions of BK virus at the molecular level. 相似文献
37.
38.
The Neoophora is characterized by the presence of complex female gonads composed of both germaria and vitellaria. The vitellaria are made up of vitelline cells that differentiate to produce and accumulate reserve substances (proteins, lipid, glycogen) and precursors of the egg capsule or cocoon shell (phenolic proteins). A comparative ultrastructural and cytochemical investigation of shell-forming globules from the vitelline cells of some neoophoran platyhelminths shows that the internal structures of the shellforming globules can be grouped into two (or three) main types. In the first, globule content is characterized by a more or less homogeneous electron-dense substructure evidently arising from repeated coalescence of small vesicles produced by the rough endoplasmic reticulum and Golgi complex. A variant of this type of globule shows intermingling (or concentric) electron-dense and translucent areas producing a pattern resembling brain convolutions (convoluted pattern). The second type of shell-globule structure shows a multigranular pattern, presumably resulting from repeated fusions of Golgian vesicles followed by incomplete coalescence of the electron-dense content. Comparison of shell-globule structure in different taxa could be useful in elucidating some complex and still-unclear phylogenetic relationships among Platyhelminthes. 相似文献
39.
B Vincze I Pályi D Daubner T Kremmer I Számel I Bodrogi J Sugár J Sepr?di I Mez? I Teplán 《The Journal of steroid biochemistry and molecular biology》1991,38(2):119-126
The specific binding of luteinizing hormone-releasing hormone (LH-RH) agonist in estradiol-dependent MCF-7 and estradiol-independent MDA-MB-231 human breast cancer cells has been studied using [3H]Ovurelin [(D-3H-Phe6),des-Gly10-LH-RH- ethylamide]. The results of Scatchard analyses suggest the presence of a single class of receptor sites, both in cell suspensions and membrane fractions. Evaluation of these peptide receptors appears to reflect additional characteristics of biological behaviour of these human breast cancer cells. The synthetic LH-RH agonist Ovurelin [(D-Phe6),des-Gly10-LH-RH-ethylamide] can directly interfere (25-30%) with the proliferation of MDA-MB-231 human breast cancer cells in culture. The inhibitory effect of Ovurelin in vitro was negligible in the MCF-7 cell line. In the in vivo experiments the treated immunosuppressed mice bearing either MCF-7 or MDA-MB-231 xenografts responded to the high-dose LH-RH analogue Zoladex depot and Decapeptyl depot therapy. Since the MDA-MB-231 tumour was found to be ER-negative it seems possible that the regression of this xenograft results from the direct antitumor action of the LH-RH agonist. 相似文献
40.
Kinetics of fructose-1,6-disphosphate aldolase (EC 4.1.2.13) catalyzed conversion of fructose phosphates was analyzed by coupling the aldolase reactions to the metabolically sequential enzyme, glycerol-3-phosphate dehydrogenase (EC 1.1.1.8), which interacts with aldolase. At low enzyme concentration poly(ethylene glycol) was added to promote complex formation of aldolase and glycerol-phosphate dehydrogenase resulting in a 3-fold increase in KM of fructose-1,6-bisphosphate and no change in Vmax. Kinetic parameters for fructose-1-phosphate conversion changed inversely upon complex formation: Vmax increased while KM remained unchanged. Gel penetration and ion-exchange chromatographic experiments showed positive modulation of the interaction of aldolase and dehydrogenase by fructose-1,6-bisphosphate. The dissociation constant of the heterologous enzyme complex decreased 10-fold in the presence of this substrate. Fructose-1-phosphate or dihydroxyacetone phosphate had no effect on the dissociation constant of the aldolase-dehydrogenase complex. In addition, titration of fluorescein-labelled glycerol-phosphate dehydrogenase with aldolase indicated that both fructose-1,6-bisphosphate and fructose-2,6-biphosphate enhanced the affinity of aldolase to glycerol-phosphate dehydrogenase. The results of the kinetic and binding experiments suggest that binding of the C-6 phosphate group of fructose-1,6-bisphosphate to aldolase complexed with dehydrogenase is sterically impeded while saturation of the C-6 phosphate group site increases the affinity of aldolase for dehydrogenase. The possible molecular mechanism of the fructose-1,6-bisphosphate modulated interaction is discussed. 相似文献